Haoran Liang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Haoran Liang has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Xiao Yang
School of Chemistry and Chemical Engineering Chongqing University of Technology Chongqing People's Republic of China
3 shared publications - Yuanqiang Wang
School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, China
3 shared publications - Haiyan Fu
Sichuan University
2 shared publications Junyi Wang
School of Chemistry and Chemical Engineering
2 shared publicationsRui Sun
School of Chemistry and Chemical Engineering
2 shared publicationsSiqi Li
Chongqing Key Lab of Medicinal Chemistry & Molecular Pharmacology, School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing 400054, P. R. China
2 shared publications
Latest Publications
- 9 August 2026
- Published by Wiley in Asian Journal of Organic Chemistry
- Vol. 15 (8)
N ‐Heterocycle Promoted the Synthesis of Tertiary Amides
A novel approach for the construction of tertiary amides via hydroamination of secondary amides with acrylates promoted by N ‐heterocycles (NHs) is described. The developed system enables a range of N ‐alkyl‐2,6‐difluorobenzamides to deliver N , N ‐dialkyl tertiary amides, which serves as a complementary alternative to existing synthetic protocols. Mechanistic studies confirm the pivotal function of NHs in this reaction system.
- 9 August 2026
- Published by Wiley in Asian Journal of Organic Chemistry
- Vol. 15 (8)
N ‐Heterocycle Promoted the Synthesis of Tertiary Amides
A novel approach for the construction of tertiary amides via hydroamination of secondary amides with acrylates promoted by N ‐heterocycles (NHs) is described. The developed system enables a range of N ‐alkyl‐2,6‐difluorobenzamides to deliver N , N ‐dialkyl tertiary amides, which serves as a complementary alternative to existing synthetic protocols. Mechanistic studies confirm the pivotal function of NHs in this reaction system.
- 14 July 2025
- Published by Wiley in ChemistrySelect
- Vol. 10 (27)
Synthesis, Characterization, and Anticancer Activity of Rhodium (III) Complexes with Bidentate and Tridentate N‐Donor Ligands
A series of five novel rhodium(III) complexes of the type [Rh(tpy)(N^N)Cl](PF 6 ) 2 , incorporating a tridentate 2,2′:6′,2′′‐terpyridine (tpy) ligand and various bidentate N‐donor ligands, were synthesized and fully characterized. The single‐crystal X‐ray diffraction analysis of complex 5 [Rh(tpy)(dppz)Cl](PF 6 ) 2 (dppz = dipyrido[3,2‐a:2′,3′‐ c ]phenazine) confirmed its octahedral geometry. Cytotoxicity assays revealed potent antiproliferative activity against four human cancer cell lines (AGS, MCF‐7, HeLa, and HepG2). Notably, complex 5 demonstrated enhanced selectivity and cytotoxicity toward AGS cells compared to cisplatin. Molecular docking studies indicated that complexes 3 and 5 effectively insert into the minor groove of calf thymus DNA (ctDNA), supported by favorable steric and electrostatic interactions. Mechanistic studies further confirmed that complex 5 induces apoptosis, causes S‐phase cell cycle arrest, and elevates intracellular ROS levels in AGS cells. Collectively, these results highlight the potential of terpyridine‐based Rh(III) complexes as promising scaffolds for metal‐based anticancer drug development.
- 14 July 2025
- Published by Wiley in ChemistrySelect
- Vol. 10 (27)
Synthesis, Characterization, and Anticancer Activity of Rhodium (III) Complexes with Bidentate and Tridentate N‐Donor Ligands
A series of five novel rhodium(III) complexes of the type [Rh(tpy)(N^N)Cl](PF 6 ) 2 , incorporating a tridentate 2,2′:6′,2′′‐terpyridine (tpy) ligand and various bidentate N‐donor ligands, were synthesized and fully characterized. The single‐crystal X‐ray diffraction analysis of complex 5 [Rh(tpy)(dppz)Cl](PF 6 ) 2 (dppz = dipyrido[3,2‐a:2′,3′‐ c ]phenazine) confirmed its octahedral geometry. Cytotoxicity assays revealed potent antiproliferative activity against four human cancer cell lines (AGS, MCF‐7, HeLa, and HepG2). Notably, complex 5 demonstrated enhanced selectivity and cytotoxicity toward AGS cells compared to cisplatin. Molecular docking studies indicated that complexes 3 and 5 effectively insert into the minor groove of calf thymus DNA (ctDNA), supported by favorable steric and electrostatic interactions. Mechanistic studies further confirmed that complex 5 induces apoptosis, causes S‐phase cell cycle arrest, and elevates intracellular ROS levels in AGS cells. Collectively, these results highlight the potential of terpyridine‐based Rh(III) complexes as promising scaffolds for metal‐based anticancer drug development.
- 14 February 2025
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 90 (8) , 3062-3070
Synthesize of β-Amino Esters from Enamides via 1,8-Diazabicyclo[5.4.0]undecane-7-ene-Mediated Hydroalkylation
A 1,8-diazabicyclo[5.4.0]undecane-7-ene (DBU)-mediated hydroalkylation of enamides with malonic acid diesters/β-carbonyl esters has been established, featuring no metal involvement, mild reaction conditions, and good functional group tolerance. The protocol enables the expedited preparation of a variety of β-amino esters. Preliminary mechanistic investigations, encompassing control experiments and capture experiments of key intermediates, have substantiated the proposed DBU-mediated hydroalkylation pathway.
- 14 February 2025
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 90 (8) , 3062-3070
Synthesize of β-Amino Esters from Enamides via 1,8-Diazabicyclo[5.4.0]undecane-7-ene-Mediated Hydroalkylation
A 1,8-diazabicyclo[5.4.0]undecane-7-ene (DBU)-mediated hydroalkylation of enamides with malonic acid diesters/β-carbonyl esters has been established, featuring no metal involvement, mild reaction conditions, and good functional group tolerance. The protocol enables the expedited preparation of a variety of β-amino esters. Preliminary mechanistic investigations, encompassing control experiments and capture experiments of key intermediates, have substantiated the proposed DBU-mediated hydroalkylation pathway.
- 8 February 2024
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 89 (5) , 3010-3019
Hydroalkoxylation of Enamides Catalyzed by N-Heteroarenium Iodides
A facile and novel N-heteroarenium iodide-catalyzed hydroalkoxylation of enamides has been described. The protocol provides easy access to N,O-acetals, which proved to be a versatile synthetic synthon. The hydrosulfonylation, hydroamination, and hydrophosphorylation products of enamide could be indirectly provided from N,O-acetals. The reaction mechanism was further investigated, which indicated that the hydroalkoxylation of enamides was driven by weak coordination between enamide and the contact ion pair of N-heteroarenium iodide.
- 8 February 2024
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 89 (5) , 3010-3019
Hydroalkoxylation of Enamides Catalyzed by N-Heteroarenium Iodides
A facile and novel N-heteroarenium iodide-catalyzed hydroalkoxylation of enamides has been described. The protocol provides easy access to N,O-acetals, which proved to be a versatile synthetic synthon. The hydrosulfonylation, hydroamination, and hydrophosphorylation products of enamide could be indirectly provided from N,O-acetals. The reaction mechanism was further investigated, which indicated that the hydroalkoxylation of enamides was driven by weak coordination between enamide and the contact ion pair of N-heteroarenium iodide.
- 4 January 2024
- Published by American Chemical Society (ACS) in Organometallics
- Vol. 43 (2) , 108-118
Rhodium(I) Complexes Containing the N^N^N-Chelating Ligand: Synthesis, Structure, and Biological Activity
- 4 January 2024
- Published by American Chemical Society (ACS) in Organometallics
- Vol. 43 (2) , 108-118
Rhodium(I) Complexes Containing the N^N^N-Chelating Ligand: Synthesis, Structure, and Biological Activity
- 30 March 2023
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 47 (18) , 8524-8537
Structural investigation of Keap1–Nrf2 protein–protein interaction (PPI) inhibitors for treating myocarditis through molecular simulations
Myocarditis is classified as an inflammatory disease of the heart muscle and is a leading cause of sudden death. The Keap1-Nrf2-ARE pathway is an important antioxidant defense mechanism that protects cells from oxidative stress and the Keap1-Nrf2 protein–protein interaction (PPI) is considered as a potential drug target against myocarditis to upregulate the expression of ARE-controlled cytoprotective oxidative stress response enzymes. To gain insights into the relationship between the activity and structure of the compounds and design superior active novel inhibitors, 3D-QSAR, molecular docking and molecular dynamics (MD) simulation were combined to investigate the interaction between Keap1–Nrf2 PPI inhibitors and Keap1. The comparative molecular field analysis (CoMFA) model (q2 = 0.907, n = 7, R2 = 0.997) and the comparative molecular similarity index analysis (CoMSIA) model (q2 = 0.900, n = 7, and R2 = 0.993) showed that the 3D-QSAR models built were credible and predictable. Based on these models, 10 new compounds were discovered and their bioactivity was validated using molecular docking and MD simulation. Furthermore, the plausible ADME/T characteristics of new compounds were evaluated and the key residues (Arg415, Tyr334, Ser602, Ser363, Arg380, etc.) in the active site were also identified by free energy calculation. The binding energy results show that the structurally optimized compounds (N1: −65.409 kcal mol−1, N3: −54.619 kcal mol−1, N4: −62.627 kcal mol−1, N5: −60.903 kcal mol−1, and N8: −66.272 kcal mol−1) have lower binding free energy values than compound 43 (ΔGbind: −49.991 kcal mol−1), indicating that they have a better affinity for the target. These findings provide necessary theoretical guidance for the discovery and design of highly active drugs against myocarditis.
- 30 March 2023
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 47 (18) , 8524-8537
Structural investigation of Keap1–Nrf2 protein–protein interaction (PPI) inhibitors for treating myocarditis through molecular simulations
Myocarditis is classified as an inflammatory disease of the heart muscle and is a leading cause of sudden death. The Keap1-Nrf2-ARE pathway is an important antioxidant defense mechanism that protects cells from oxidative stress and the Keap1-Nrf2 protein–protein interaction (PPI) is considered as a potential drug target against myocarditis to upregulate the expression of ARE-controlled cytoprotective oxidative stress response enzymes. To gain insights into the relationship between the activity and structure of the compounds and design superior active novel inhibitors, 3D-QSAR, molecular docking and molecular dynamics (MD) simulation were combined to investigate the interaction between Keap1–Nrf2 PPI inhibitors and Keap1. The comparative molecular field analysis (CoMFA) model (q2 = 0.907, n = 7, R2 = 0.997) and the comparative molecular similarity index analysis (CoMSIA) model (q2 = 0.900, n = 7, and R2 = 0.993) showed that the 3D-QSAR models built were credible and predictable. Based on these models, 10 new compounds were discovered and their bioactivity was validated using molecular docking and MD simulation. Furthermore, the plausible ADME/T characteristics of new compounds were evaluated and the key residues (Arg415, Tyr334, Ser602, Ser363, Arg380, etc.) in the active site were also identified by free energy calculation. The binding energy results show that the structurally optimized compounds (N1: −65.409 kcal mol−1, N3: −54.619 kcal mol−1, N4: −62.627 kcal mol−1, N5: −60.903 kcal mol−1, and N8: −66.272 kcal mol−1) have lower binding free energy values than compound 43 (ΔGbind: −49.991 kcal mol−1), indicating that they have a better affinity for the target. These findings provide necessary theoretical guidance for the discovery and design of highly active drugs against myocarditis.
- 26 January 2023
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 59 (15) , 2126-2129
A diphosphoramidite ligand for hydroformylation of various olefins
A new rotationally hindered diphosphoramidite ligand has been applied to the Rh-catalyzed hydroformylation of various olefins.
- 26 January 2023
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 59 (15) , 2126-2129
A diphosphoramidite ligand for hydroformylation of various olefins
A new rotationally hindered diphosphoramidite ligand has been applied to the Rh-catalyzed hydroformylation of various olefins.
- Open Access
- 1 December 2022
- Published by Frontiers Media SA in Frontiers in Chemistry
- Vol. 10, 1091243
Advances in hydrophilic metal–organic frameworks for N-linked glycopeptide enrichment
The comprehensive profiling of glycoproteins is of great significance for the timely clinical diagnosis and therapy. However, inherent obstacles hamper their direct analysis from biological samples, and specific enrichment prior to analysis is indispensable. Among the various approaches for glycopeptide enrichment, hydrophilic interaction liquid chromatography (HILIC) has attracted special focus, especially for the development of novel hydrophilic materials, which is the key of HILIC. Metal–organic frameworks (MOFs) are a type of porous materials constructed from the self-assembly of metal and organic linkers. Advantages such as high surface area, flexible pore size, and easy modification render hydrophilic MOFs as ideal candidates for HILIC, which has inspired many studies over the past years. In this review, advances in hydrophilic MOFs for N-linked glycopeptide enrichment are summarized. According to the synthesis strategies, those materials are categorized into three classes, namely pristine MOFs, MOFs with chemical modifications, and MOFs-derived composite. In each categorization, the preparation and the function of different moieties are covered, as well as the enrichment performances of sensitivity, selectivity, and practical application. Finally, a summary and future perspective on the applications of hydrophilic MOFs for N-linked glycopeptide enrichment are briefly discussed. This review is expected to raise awareness of the properties of hydrophilic MOFs and offer some valuable information to further research in glycoproteomics.
- 1 December 2022
- Published by Frontiers Media SA in Frontiers in Chemistry
- Vol. 10, 1091243
Open AccessAdvances in hydrophilic metal–organic frameworks for N-linked glycopeptide enrichment
The comprehensive profiling of glycoproteins is of great significance for the timely clinical diagnosis and therapy. However, inherent obstacles hamper their direct analysis from biological samples, and specific enrichment prior to analysis is indispensable. Among the various approaches for glycopeptide enrichment, hydrophilic interaction liquid chromatography (HILIC) has attracted special focus, especially for the development of novel hydrophilic materials, which is the key of HILIC. Metal–organic frameworks (MOFs) are a type of porous materials constructed from the self-assembly of metal and organic linkers. Advantages such as high surface area, flexible pore size, and easy modification render hydrophilic MOFs as ideal candidates for HILIC, which has inspired many studies over the past years. In this review, advances in hydrophilic MOFs for N-linked glycopeptide enrichment are summarized. According to the synthesis strategies, those materials are categorized into three classes, namely pristine MOFs, MOFs with chemical modifications, and MOFs-derived composite. In each categorization, the preparation and the function of different moieties are covered, as well as the enrichment performances of sensitivity, selectivity, and practical application. Finally, a summary and future perspective on the applications of hydrophilic MOFs for N-linked glycopeptide enrichment are briefly discussed. This review is expected to raise awareness of the properties of hydrophilic MOFs and offer some valuable information to further research in glycoproteomics.
- 29 June 2022
- Published by Springer Nature in Molecular Diversity
- Vol. 27 (3) , 1123-1140
Three-dimensional quantitative structural-activity relationship and molecular dynamics study of multivariate substituted 4-oxyquinazoline HDAC6 inhibitors
3D-QSAR models were established by collecting 46 multivariate-substituted 4-oxyquinazoline HDAC6 inhibitors. The relationship of molecular structure and inhibitory activity was studied by comparative molecular field analysis (CoMFA) and comparative molecular similarity index analysis (CoMSIA). The results showed the models established by CoMFA (q2 = 0.590, r2 = 0.965) and CoMSIA (q2 = 0.594, r2 = 0.931) had good prediction ability. At the same time, 3D-QSAR models met the internal verification, external verification and AD test. Ten new compounds were designed based on CoMFA and CoMSIA contour maps and their pharmacokinetic/toxic properties (ADME/T) were evaluated. It was found that most compounds have well safety profile and pharmacokinetic property. Then, we explored the interaction between HDAC6 and compounds by molecular docking. The results showed that the binding mode of the new compounds with HDAC6 was the same as the template compound 46, and the hydrogen bond and hydrophobic bond played a vital role in the binding process. Molecular dynamics simulation results showed that residues Ser531, His574 and Tyr745 played key roles in the binding process. All newly designed compounds had lower energy gap and binding energy than compound 46 according to DFT analysis and free energy analysis. This study provided a theoretical reference for designing compounds of higher activity and a new idea for the development of novel HDAC6 inhibitors. Graphical abstract
- 29 June 2022
- Published by Springer Nature in Molecular Diversity
- Vol. 27 (3) , 1123-1140
Three-dimensional quantitative structural-activity relationship and molecular dynamics study of multivariate substituted 4-oxyquinazoline HDAC6 inhibitors
3D-QSAR models were established by collecting 46 multivariate-substituted 4-oxyquinazoline HDAC6 inhibitors. The relationship of molecular structure and inhibitory activity was studied by comparative molecular field analysis (CoMFA) and comparative molecular similarity index analysis (CoMSIA). The results showed the models established by CoMFA (q2 = 0.590, r2 = 0.965) and CoMSIA (q2 = 0.594, r2 = 0.931) had good prediction ability. At the same time, 3D-QSAR models met the internal verification, external verification and AD test. Ten new compounds were designed based on CoMFA and CoMSIA contour maps and their pharmacokinetic/toxic properties (ADME/T) were evaluated. It was found that most compounds have well safety profile and pharmacokinetic property. Then, we explored the interaction between HDAC6 and compounds by molecular docking. The results showed that the binding mode of the new compounds with HDAC6 was the same as the template compound 46, and the hydrogen bond and hydrophobic bond played a vital role in the binding process. Molecular dynamics simulation results showed that residues Ser531, His574 and Tyr745 played key roles in the binding process. All newly designed compounds had lower energy gap and binding energy than compound 46 according to DFT analysis and free energy analysis. This study provided a theoretical reference for designing compounds of higher activity and a new idea for the development of novel HDAC6 inhibitors. Graphical abstract
- 1 May 2014
- Published by Elsevier in Catalysis Communications
- Vol. 50, 29-33
Highly efficient catalytic system for the formation of dialdehydes from dicyclopentadiene hydroformylation
- 1 May 2014
- Published by Elsevier in Catalysis Communications
- Vol. 50, 29-33
Highly efficient catalytic system for the formation of dialdehydes from dicyclopentadiene hydroformylation